Design Therapeutics, Inc. DSGN Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s current ratio?
- Design Therapeutics, Inc. (DSGN) reported current ratio of 22.3× in Q1 2026.
- How has Design Therapeutics, Inc.'s current ratio changed year-over-year?
- Design Therapeutics, Inc.'s current ratio decreased by 21.5% year-over-year, from 28.4× to 22.3×.
- What is the long-term trend for Design Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s current ratio has grown at a 2.0% compound annual growth rate (CAGR), from 15.6× to 17.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.